X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-11 | DYN | Farwell Wildon | Chief Medical Officer | S - Sale | $25.65 | -2,615 | 150,560 | -2% | -$67,082 | |||||
2024-03-07 | DYN | Farwell Wildon | Chief Medical Officer | S - Sale | $25.86 | -9,921 | 153,175 | -6% | -$256,585 | ||||||
2024-02-12 | DYN | Farwell Wildon | Chief Medical Officer | S - Sale | $25.07 | -5,493 | 163,503 | -3% | -$137,710 | ||||||
2024-01-26 | DYN | Farwell Wildon | Chief Medical Officer | S - Sale | $25.00 | -100 | 168,996 | 0% | -$2,500 | ||||||
| M | 2023-12-11 | DYN | Farwell Wildon | Chief Medical Officer | S - Sale | $10.66 | -2,666 | 169,096 | -2% | -$28,413 | |||||
2023-09-12 | DYN | Farwell Wildon | Chief Medical Officer | S - Sale | $10.41 | -1,707 | 89,250 | -2% | -$17,770 | ||||||
2023-06-13 | DYN | Farwell Wildon | Chief Medical Officer | S - Sale | $12.43 | -1,698 | 90,957 | -2% | -$21,106 | ||||||
2023-03-14 | DYN | Farwell Wildon | Chief Medical Officer | S - Sale | $13.33 | -7,441 | 92,655 | -7% | -$99,189 | ||||||
| D | 2022-12-12 | DYN | Farwell Wildon | Chief Medical Officer | S - Sale+OE | $10.87 | -628 | 100,096 | -1% | -$6,826 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |